Electronic Prior Authorization Tool Could Aid Evidence-Based Prescribing
Executive Summary
An electronic prescribing tool that automates prior authorization decisions is a first step towards using e-prescribing to help physicians adhere to clinical guidelines, Pfizer Strategic Technology Group Director Ross Martin told a July 26 meeting of the National Committee on Vital & Health Statistics/Standards & Security Subcommittee
You may also be interested in...
Medicare E-Prescribing Rule Proposes “Foundation Standards” For Jan. 1
Electronic prescribing systems used under Medicare Part D would be required to include information about comparative copayments under HHS' draft e-prescribing standards rule
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials